共 17 条
[1]
Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therapy?
[J].
EUROPEAN HEART JOURNAL,
2012, 33 (11)
:1325-1333
[4]
Clinical Follow-Up 3 Years After Everolimus- and Paclitaxel-Eluting Stents A Pooled Analysis From the SPIRIT II (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions) and SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) Randomized Trials
[J].
JACC-CARDIOVASCULAR INTERVENTIONS,
2010, 3 (12)
:1220-1228
[6]
Di Mario Carlo, 2009, EuroIntervention, V5 Suppl F, pF103, DOI 10.4244/EIJV5IFA18
[10]
Latib A, J AM COLL C IN PRESS